Inventor · disambiguated record
Harvey Lodish
Also filed as: LODISH HARVEY · LODISH HARVEY F
33 granted patents·21 pending applications·470 citations·filing 1990–2023
97Inventor score
Files withWHITEHEAD BIOMEDICAL INST27WHITEHEAD INST BIOMEDICAL RES5UNIV CASE WESTERN RESERVE3ZHANG CHENGCHENG3ARRIS PHARM CORP2
Top patents by PatentIndex Score
54 records- 0195US7767453B2Cultured hematopoietic stem cells and method for expansion and analysis thereofWHITEHEAD BIOMEDICAL INST·Filed 2005·Granted Aug 3, 2010·38 cites·27 claims
- 0293US7807464B2Methods for expansion and analysis of cultured hematopoietic stem cellsWHITEHEAD BIOMEDICAL INST·Filed 2006·Granted Oct 5, 2010·27 cites·39 claims
- 0390US10471099B2In vitro production of red blood cells with proteins comprising sortase recognition motifsWHITEHEAD INST BIOMEDICAL RES·Filed 2014·Granted Nov 12, 2019·20 cites·21 claims
- 0489US7405193B2Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiationSERONO GENETICS INST SA·Filed 2001·Granted Jul 29, 2008·30 cites·36 claims
- 0588US11266695B2In vitro production of red blood cells with sortaggable proteinsWHITEHEAD INST BIOMEDICAL RES·Filed 2018·Granted Mar 8, 2022·4 cites·30 claims
- 0687US6303373B1Method of measuring plasma membrane targeting of GLUT4WHITEHEAD BIOMEDICAL INST·Filed 2000·Granted Oct 16, 2001·24 cites·28 claims
- 0784US8106180B2Methods and products for expression of micro RNAsCHEN CHANG-ZHENG·Filed 2004·Granted Jan 31, 2012·10 cites·36 claims
- 0884US5869330ADNA encoding a novel serum protein produced exclusively in adipocytesWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Feb 9, 1999·50 cites·5 claims
- 0983US6001969ARecombinant TGF-β type II receptor polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Dec 14, 1999·40 cites·18 claims
- 1082US6955895B2Thymic stromal lymphopoietin receptor molecules and uses thereofHEALTH RES INC ROSEWELL PARK D·Filed 2001·Granted Oct 18, 2005·16 cites·15 claims
- 1181US6008011ATGF-β type II receptor cDNAsWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Dec 28, 1999·34 cites·24 claims
- 1280US6010872ARecombinant production of TGF-β type III receptor (betaglycan) polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1994·Granted Jan 4, 2000·25 cites·40 claims
- 1379US6632924B2Method of measuring plasma membrane targeting of GLUT4WHITEHEAD BIOMEDICAL INST·Filed 2001·Granted Oct 14, 2003·9 cites·29 claims
- 1475US5292654AMutant EPO receptor and uses thereforWHITEHEAD BIOMEDICAL INST·Filed 1990·Granted Mar 8, 1994·51 cites·3 claims
- 1571US11992505B2In vitro production of red blood cells with proteins comprising sortase recognition motifsWHITEHEAD INST BIOMEDICAL RES·Filed 2019·Granted May 28, 2024·0 cites·24 claims
- 1667US11970718B2Nucleic acid loaded extracellular vesiclesCARMINE THERAPEUTICS PTE LTD·Filed 2021·Granted Apr 30, 2024·1 cites·22 claims
- 1767US2008274971A1Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle DifferentiationSERONO GENETICS INST SA·Filed 2008·Application pending·0 cites
- 1866US6201108B1TGF-β type receptor cDNAs encoded products and uses thereforWHITEHEAD INST FOR MEDICAL RES·Filed 1995·Granted Mar 13, 2001·15 cites·6 claims
- 1965US12281314B2Methods and compositions for increasing protein expression and/or treating a haploinsufficiency disorderUNIV CASE WESTERN RESERVE·Filed 2019·Granted Apr 22, 2025·0 cites·10 claims
- 2064US11617802B2Methods and compositions for treating a premature stop codon-mediated disorderUNIV CASE WESTERN RESERVE·Filed 2021·Granted Apr 4, 2023·0 cites·6 claims
- 2164US6046157AModulation of TGF-β by recombinant TGF-β type II receptor polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Apr 4, 2000·12 cites·21 claims
- 2263US6348321B1Methods of identifying agents inhibiting fatty acid transport proteinsWHITEHEAD BIOMEDICAL INST·Filed 1999·Granted Feb 19, 2002·14 cites·80 claims
- 2363US6284487B1Polynucleotides encoding fatty acid transport proteinsWHITEHEAD BIOMEDICAL INST·Filed 1999·Granted Sep 4, 2001·14 cites·80 claims
- 2463US2008234216A1TGF-beta type receptor cDNAs encoded products and uses thereforLIN HERBERT Y·Filed 2007·Application pending·0 cites
- 2561US2014234266A1Cultured Hematopoietic Stem Cells and Method for Expansion and Analysis ThereofWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 2661US2024050594A1Methods and compositions for treating a premature stop codon-mediated disorderUNIV CASE WESTERN RESERVE·Filed 2023·Application pending·0 cites
- 2760US8609832B2Methods and products for expression of micro RNAsCHEN CHANG-ZHENG·Filed 2011·Granted Dec 17, 2013·0 cites·11 claims
- 2860US2006247198A1TGF-beta type receptor cDNAs encoded products and uses thereforLIN HERBERT Y·Filed 2006·Application pending·0 cites
- 2959US7402659B2Thymic stromal lymphopoietin receptor molecules and uses thereofWHITEHEAD BIOMEDICAL INST·Filed 2005·Granted Jul 22, 2008·0 cites·19 claims
- 3059US6288213B1Fatty acid transport proteinsWHITEHEAD INST FOR BIOCHEMICAL·Filed 1999·Granted Sep 11, 2001·13 cites·14 claims
- 3159US2014017784A1Methods for Expansion and Analysis of Cultured Hematopoietic Stem CellsWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 3258US8617885B2Cultured hematopoietic stem cells and method for expansion and analysis thereofZHANG CHENGCHENG·Filed 2010·Granted Dec 31, 2013·0 cites·17 claims
- 3358US8609411B2Ex vivo expansion of human hematopoietic stem cellsZHANG CHENGCHENG·Filed 2008·Granted Dec 17, 2013·0 cites·20 claims
- 3458US6086867AModulation of TGF-β by TGF-β type III receptor polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1998·Granted Jul 11, 2000·8 cites·20 claims
- 3558US2014187613A1METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAsWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 3656US2005260579A1TGF-beta type receptor cDNAs encoded productsWHITEHEAD BIOMEDICAL INST·Filed 2003·Application pending·0 cites
- 3754US8506955B2Methods for expansion and analysis of cultured hematopoietic stem cellsZHANG CHENGCHENG·Filed 2010·Granted Aug 13, 2013·0 cites·19 claims
- 3854US2003177515A1Transgenic mammals lacking expression of erythropoietin or of erythropoietin receptor, transgenic mammals expressing chimeric erythropoietin receptors, constructs for producing the transgenic mammals and uses thereforARRIS PHARM CORP·Filed 2002·Application pending·0 cites
- 3951US2002106733A1Fatty acid transport proteinsWHITEHEAD BIOMEDICAL INST·Filed 2001·Application pending·0 cites
- 4051US2014308747A1Ex Vivo Expansion of Human Hematopoietic Stem CellsWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 4150US2003232363A1Fatty acid transport proteinsFiled 2003·Application pending·0 cites
- 4246US6300096B1Polynucleotides encoding fatty acid transport proteinsWHITEHEAD BIOMEDICAL INST·Filed 1999·Granted Oct 9, 2001·11 cites·66 claims
- 4346US2020206269A1Production of enucleated red blood cells and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2018·Application pending·0 cites
- 4445US11371019B2Efficient generation of human red blood cells via enriching peripheral blood erythroid progenitorsWHITEHEAD INST BIOMEDICAL RES·Filed 2017·Granted Jun 28, 2022·0 cites·28 claims
- 4545US2002168660A1Stem cell self-renewal and lineage commitmentWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 4645US2003064061A1Bcr-Abl oligomerization domain polypeptides and uses thereforWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 4744US2007212686A1Use Of T-Cadherin As A TargetWHITEHEAD BIOMEDICAL INST·Filed 2004·Application pending·0 cites
- 4843US2004126788A1Fibulin-5 and uses thereofFiled 2003·Application pending·0 cites
- 4943US2003165430A1Transgenic fatty acid transport one (FATP1) non-human knockout mammals uses thereofWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 5042US2002155479A1Expression cloning methodWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Harvey Lodish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →